5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
Open Access
- 1 February 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 177 (1-2), 95-98
- https://doi.org/10.1016/0014-2999(90)90555-k
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Antidepressant interactions with 5-hydroxytryptamine3 receptor binding sitesEuropean Journal of Pharmacology, 1989
- Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicityJournal of Neuroscience, 1988
- Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sitesEuropean Journal of Pharmacology, 1988
- New Data Intensify the Agony Over EcstasyScience, 1988
- Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brainBiochemical Pharmacology, 1987
- [3H]3,4-Methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paperEuropean Journal of Pharmacology, 1987
- In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brainBiochemical Pharmacology, 1987
- NEUROTOXICITY OF THE PSYCHEDELIC AMPHETAMINE, METHYLENEDIOXYMETHAMPHETAMINE1987
- Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slicesEuropean Journal of Pharmacology, 1986